Uncarinicacid E has anti-cancer activity, it induces apoptosis in HepG2 cells via accumulation of p53, alters the Bax Bcl-2 ratio, and activates caspases, resulting in cytochrome c release from the mitochondria. A mixture of uncarinicacid E and 27-O-p-(